JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
Cohu
COHU
$3.33B
| $1.09M | ﹤0.01% |
80,667
-389,987
| -83% | -$5.41M |
2015 Q1
18 quarters
|
|
|
RPT
3627
Rithm Property Trust
RPT
$83.6M
| $1.09M | ﹤0.01% |
12,098
+3,566
| +42% | +$299K |
2017 Q3
8 quarters
|
|
3628
SPX Corp
SPXC
$8.5B
| $1.09M | ﹤0.01% |
27,143
-2,964
| -10% | -$109K |
2013 Q2
25 quarters
|
|
3629
Star Bulk Carriers
SBLK
$3.53B
| $1.08M | ﹤0.01% |
107,744
+13,690
| +15% | +$139K |
2017 Q3
8 quarters
|
|
|
GRTS
3630
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.08M | ﹤0.01% |
125,470
+4,875
| +4% | +$49.3K |
2018 Q3
4 quarters
|
|
|
SASR
3631
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.08M | ﹤0.01% |
32,083
-12,617
| -28% | -$437K |
2015 Q4
15 quarters
|
|
3632
QuidelOrtho
QDEL
$712M
| $1.08M | ﹤0.01% |
17,607
+308
| +2% | +$18.5K |
2015 Q3
16 quarters
|
|
3633
Allient
ALNT
$1.97B
| $1.08M | ﹤0.01% |
45,744
+813
| +2% | +$19.8K |
2017 Q4
7 quarters
|
|
|
CNR
3634
Core Natural Resources Inc
CNR
$4.35B
| $1.08M | ﹤0.01% |
68,871
-115,449
| -63% | -$2.26M |
2017 Q4
7 quarters
|
|
|
BGX
3635
Blackstone Long-Short Credit Income Fund
BGX
$134M
| $1.08M | ﹤0.01% |
68,211
-4,960
| -7% | -$79.4K |
2018 Q2
5 quarters
|
|
3636
Magnite
MGNI
$3.65B
| $1.07M | ﹤0.01% |
122,927
+37,421
| +44% | +$328K |
2014 Q2
21 quarters
|
|
3637
Tootsie Roll Industries
TR
$2.84B
| $1.07M | ﹤0.01% |
35,488
+1,692
| +5% | +$51K |
2013 Q2
25 quarters
|
|
|
EXTN
3638
DELISTED
Exterran Corporation
EXTN
| $1.07M | ﹤0.01% |
81,790
+58,928
| +258% | +$712K |
2015 Q4
15 quarters
|
|
3639
Surgery Partners
SGRY
$1.73B
| $1.07M | ﹤0.01% |
144,330
+6,603
| +5% | +$47.3K |
2016 Q4
11 quarters
|
|
3640
Impinj
PI
$5.62B
| $1.06M | ﹤0.01% |
34,533
-18,577
| -35% | -$649K |
2016 Q3
12 quarters
|
|
|
BSTC
3641
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.06M | ﹤0.01% |
19,871
+8,188
| +70% | +$477K |
2017 Q4
7 quarters
|
|
3642
First Trust Consumer Staples AlphaDEX Fund
FXG
$201M
| $1.06M | ﹤0.01% |
22,000
-123
| -0.6% | -$5.76K |
2013 Q2
25 quarters
|
|
3643
US Physical Therapy
USPH
$1.23B
| $1.06M | ﹤0.01% |
8,142
+3,677
| +82% | +$479K |
2015 Q4
15 quarters
|
|
|
LJPC
3644
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.06M | ﹤0.01% |
120,090
+5,451
| +5% | +$51.5K |
2017 Q4
7 quarters
|
|
|
NMCI
3645
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
| $1.05M | ﹤0.01% |
529,163
-26,899
| -5% | -$55.4K |
2018 Q4
3 quarters
|
|
3646
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.32B
| $1.05M | ﹤0.01% |
20,349
-2,673
| -12% | -$137K |
2013 Q4
23 quarters
|
|
3647
KRONOS Worldwide
KRO
$878M
| $1.05M | ﹤0.01% |
84,812
+44,348
| +110% | +$550K |
2017 Q4
7 quarters
|
|
3648
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.1B
| $1.05M | ﹤0.01% |
7,086
-8,483
| -54% | -$1.27M |
2015 Q4
15 quarters
|
|
3649
PUT
Factset
FDS
$9.87B
| $1.04M | ﹤0.01% |
+4,300
| New | +$1.19M |
2019 Q3
0 quarters
|
|
3650
Iridium Communications
IRDM
$5.07B
| $1.04M | ﹤0.01% |
48,780
-51,812
| -52% | -$1.23M |
2014 Q4
19 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.